Rikke Lyngaa

4.3k total citations
16 papers, 870 citations indexed

About

Rikke Lyngaa is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Rikke Lyngaa has authored 16 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Rikke Lyngaa's work include Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (6 papers) and T-cell and B-cell Immunology (6 papers). Rikke Lyngaa is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (6 papers) and T-cell and B-cell Immunology (6 papers). Rikke Lyngaa collaborates with scholars based in Denmark, United States and Netherlands. Rikke Lyngaa's co-authors include Sine Reker Hadrup, Per thor Straten, Inge Marie Svane, Marco Donia, Rikke Andersen, Ton N. Schumacher, Charlotte Albæk Thrue, Thomas Mørch Frøsig, Paul Nghiem and Jürgen C. Becker and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and Cancer Research.

In The Last Decade

Rikke Lyngaa

16 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rikke Lyngaa Denmark 13 567 560 239 125 102 16 870
Ilana M. Roberts United States 8 972 1.7× 801 1.4× 205 0.9× 60 0.5× 45 0.4× 10 1.2k
Cathrin Ritter Germany 14 647 1.1× 258 0.5× 199 0.8× 256 2.0× 207 2.0× 23 840
Melissa Videtta Italy 10 283 0.5× 305 0.5× 50 0.2× 105 0.8× 59 0.6× 11 566
Ivy Lai United States 9 525 0.9× 359 0.6× 81 0.3× 135 1.1× 115 1.1× 14 600
Oliver Ast Switzerland 7 196 0.3× 294 0.5× 117 0.5× 33 0.3× 20 0.2× 11 531
Alon Vitenshtein Israel 11 287 0.5× 427 0.8× 143 0.6× 49 0.4× 21 0.2× 16 709
Muharrem Müftüoğlu United States 14 264 0.5× 166 0.3× 171 0.7× 77 0.6× 15 0.1× 54 587
E Soeda Japan 12 266 0.5× 86 0.2× 240 1.0× 35 0.3× 31 0.3× 15 552
Deniz Duralı France 11 189 0.3× 310 0.6× 48 0.2× 63 0.5× 29 0.3× 14 506
Sophia Z. Shalhout United States 11 366 0.6× 164 0.3× 314 1.3× 37 0.3× 28 0.3× 41 748

Countries citing papers authored by Rikke Lyngaa

Since Specialization
Citations

This map shows the geographic impact of Rikke Lyngaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rikke Lyngaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rikke Lyngaa more than expected).

Fields of papers citing papers by Rikke Lyngaa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rikke Lyngaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rikke Lyngaa. The network helps show where Rikke Lyngaa may publish in the future.

Co-authorship network of co-authors of Rikke Lyngaa

This figure shows the co-authorship network connecting the top 25 collaborators of Rikke Lyngaa. A scholar is included among the top collaborators of Rikke Lyngaa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rikke Lyngaa. Rikke Lyngaa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Bentzen, Amalie Kai, Kamilla Kjærgaard Jensen, Andrea Marion Marquard, et al.. (2018). T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide–MHC complexes. Nature Biotechnology. 36(12). 1191–1196. 68 indexed citations
3.
Becker, Jürgen C., Andreas Stang, Axel zur Hausen, et al.. (2017). Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC. Cancer Immunology Immunotherapy. 67(3). 341–351. 73 indexed citations
4.
Erdmann, Michael, Sine Reker Hadrup, Rikke Lyngaa, et al.. (2017). Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination. Therapeutic Advances in Medical Oncology. 9(7). 451–464. 19 indexed citations
5.
Donia, Marco, Julie Westerlin Kjeldsen, Rikke Andersen, et al.. (2017). PD-1+ Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer. Clinical Cancer Research. 23(19). 5779–5788. 39 indexed citations
6.
Lyngaa, Rikke, Rikke Andersen, Lisbet Rosenkrantz Hölmich, et al.. (2017). Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma. Oncotarget. 8(16). 27062–27074. 27 indexed citations
7.
Bentzen, Amalie Kai, Andrea Marion Marquard, Rikke Lyngaa, et al.. (2016). Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nature Biotechnology. 34(10). 1037–1045. 216 indexed citations
8.
Frøsig, Thomas Mørch, Rikke Lyngaa, Özcan Met, et al.. (2015). Broadening the repertoire of melanoma-associated T-cell epitopes. Cancer Immunology Immunotherapy. 64(5). 609–620. 8 indexed citations
9.
Frøsig, Thomas Mørch, Tina Seremet, Rikke Lyngaa, et al.. (2015). Design and validation of conditional ligands for HLA‐B*08:01, HLA‐B*15:01, HLA‐B*35:01, and HLA‐B*44:05. Cytometry Part A. 87(10). 967–975. 13 indexed citations
10.
Lyngaa, Rikke, Natasja Wulff Pedersen, David Schrama, et al.. (2014). T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors. Clinical Cancer Research. 20(7). 1768–1778. 76 indexed citations
11.
Donia, Marco, et al.. (2014). Effects of ipilimumab on expanded tumor-infiltrating lymphocytes in patients with stage IV malignant melanoma.. Journal of Clinical Oncology. 32(15_suppl). 3020–3020. 3 indexed citations
12.
Gang, Anne Ortved, Thomas Mørch Frøsig, Marie K. Brimnes, et al.. (2014). 5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies. Blood Cancer Journal. 4(3). e197–e197. 65 indexed citations
13.
Andersen, Rikke Sick, Sofie Ramskov, Rikke Lyngaa, et al.. (2013). High frequency of T cells specific for cryptic epitopes in melanoma patients. OncoImmunology. 2(7). e25374–e25374. 19 indexed citations
14.
Andersen, Rikke, Charlotte Albæk Thrue, Niels Junker, et al.. (2012). Dissection of T-cell Antigen Specificity in Human Melanoma. Cancer Research. 72(7). 1642–1650. 119 indexed citations
15.
Andersen, Rikke, Pia Kvistborg, Thomas Mørch Frøsig, et al.. (2012). Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers. Nature Protocols. 7(5). 891–902. 82 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilana M. Roberts Breakdown of academic impact, for papers by Cathrin Ritter Breakdown of academic impact, for papers by Melissa Videtta Breakdown of academic impact, for papers by Ivy Lai Breakdown of academic impact, for papers by Oliver Ast Breakdown of academic impact, for papers by Alon Vitenshtein Breakdown of academic impact, for papers by Muharrem Müftüoğlu Breakdown of academic impact, for papers by E Soeda Breakdown of academic impact, for papers by Deniz Duralı Breakdown of academic impact, for papers by Sophia Z. Shalhout
Rankless by CCL
2026